LH (Labcorp Holdings) ROCE %: 9.37% (As of Mar. 2026)

What is Labcorp Holdings ROCE %?

Labcorp Holdings LH +1.85% 79 ROCE % is 9.37% as of Mar. 2026. GuruFocus rates LH with a GF Score™ of 79/100 and a GF Value™ of $271.41 (Fairly Valued). The stock has 6 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Labcorp Holdings's annualized ROCE % for the quarter that ended in Mar. 2026 was 9.37%.

Labcorp Holdings (NYSE:LH) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Labcorp Holdings ROCE % Related Terms

Labcorp Holdings ROCE % Historical Data

* Premium members only.

The historical data trend for Labcorp Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Labcorp Holdings ROCE % Chart

Labcorp Holdings Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROCE %

Get a 7-Day Free Trial

17.92

8.17

5.03

8.18

8.70

Labcorp Holdings Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															8.66	9.37	10.15	6.30	9.37

79GF Score

Labcorp Holdings Inc LH

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Labcorp Holdings ROCE % Calculation

Labcorp Holdings's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	1331.6	/	( ( (18379 - 3330.2)	+	(18392.7 - 2823.5) )	/ 2 )
	=	1331.6	/	( (15048.8	+	15569.2)	/ 2 )
	=	1331.6	/	15309
	=	8.70 %

Labcorp Holdings's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	1499.2	/	( ( (18392.7 - 2823.5)	+	(19087.1 - 2641) )	/ 2 )
	=	1499.2	/	( ( 15569.2	+	16446.1 )	/ 2 )
	=	1499.2	/	16007.65
	=	9.37 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of 9.37% mean?

Labcorp Holdings (LH) has a ROCE % of 9.37% as of Mar. 2026.

Is Labcorp Holdings' ROCE % too high?

Labcorp Holdings' current ROCE % is 9.37%. Overall, Labcorp Holdings has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does Labcorp Holdings' ROCE % compare to DGX and MTD?

Labcorp Holdings' ROCE % of 9.37% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Medical Diagnostics & Research company?

A good ROCE % depends on the Medical Diagnostics & Research industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. Labcorp Holdings's current ROCE % is 9.37%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Labcorp Holdings stock overvalued right now?

Based on GuruFocus' analysis, Labcorp Holdings (LH) is currently considered Fairly Valued. The stock's GF Value™ is $271.41, compared to a current price of $270.08 — trading 0.5% below its estimated fair value. The current ROCE % is 9.37%. Labcorp Holdings' overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Labcorp Holdings (LH), the current ROCE % is 9.37% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Labcorp Holdings (LH) Overvalued in 2026?

Based on GuruFocus' analysis, Labcorp Holdings stock appears to be undervalued. The current stock price of $270.08 is trading 0.5% below its estimated GF Value™ of $271.41. GuruFocus considers Labcorp Holdings to be Fairly Valued.

Key valuation signals for LH:

ROCE %: 9.37%
GF Value™: $271.41 vs. price of $270.08 (0.5% below fair value)
GF Score™: 79/100 with 6 warning signs

No single metric tells the full story. See the LH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Labcorp Holdings Business Description

Industry Healthcare Medical Diagnostics & Research

Comparable Companies DGX MTD ILMN GH MEDP IQV RVTY NTRA ICLR CRL TMO DHR SHSE:603259 XSWX:LONN IDXX A WAT XPAR:ERF XPAR:BIM HKSE:02268

Other Exchanges 0JSY:UK N6B:Germany

Address 358 South Main Street, Burlington, NC, USA, 27215

Website https://www.labcorp.com

Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.

79GF Score

Get the complete analysis for LH

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$270.08

Price

$271.41

GF Value

View LH Analysis

See ROCE % data for all stocks →